@ElsLifeSciences Profile picture

Elsevier for Life Sciences

@ElsLifeSciences

Innovate and prioritize faster and safer with actionable data and AI

Similar User
J Org Chem/Org Lett photo

@JOC_OL

ACS Publications Bio & Med Chem Content photo

@ACSBioMed

Stoltz Group photo

@thestoltzgroup

Chem Soc Rev photo

@ChemSocRev

ACS for Authors photo

@ACS4Authors

SciFinder photo

@SciFinder

RealTimeChem (no longer active) photo

@RealTimeChem

HelvChimActa photo

@HelvChimActa

ACS Publications photo

@ACSPublications

Shenvi Lab photo

@Shenvi_Lab

Elsevier Chemistry photo

@ELSchemistry

OBC photo

@OrgBiomolChem

RSC Advances photo

@RSCAdvances

Princeton Chemistry photo

@PrincetonChem

CAS photo

@CASChemistry

Watch Novartis experts explain the predictive model life cycle in #DrugDiscovery in four steps 👩‍🔬 And discover how #AI can advance drug discovery research here: spkl.io/6016fpk8o


🧪 Curious about how #SCD1 affects glucose homeostasis in diabetes? Join our webinar today to delve into bioactivity and therapeutic strategies! 📲 Register now: spkl.io/6014fRq1s #DrugDiscovery #Pharmacology #NationalDiabetesMonth #Elsevier


Join experts in #diabetes research to explore how #SCD1 and bioactive compounds interact in disease treatment. 📲 Register today: spkl.io/6010fRqDs #DrugDiscovery #DiabetesManagement #Elsevier


🧪 Dive into diabetes research with us: discover how #SCD1 affects #bioactivity and what this means for #drug design and treatment strategies. 🔗 Register: spkl.io/6012fTXxi #DiabetesResearch #LifeScienceSolutions #Elsevier


🧪 Curious about how #SCD1 affects glucose homeostasis in diabetes? Join our webinar on Nov 13th to delve into bioactivity and therapeutic strategies! 📲 Register now: spkl.io/6011fRqBx #DrugDiscovery #Pharmacology #NationalDiabetesMonth #Elsevier


EmBiology is a tool that will help you visualize millions of biological relationships to gain a fast understanding of disease #biology, and quickly and easily interpret experimental #data. Get a quick overview below and learn more here: spkl.io/6015fzImZ #Research


Join us on Nov 13th to explore key insights and learn how StearoylCoA9desaturase (#SCD1) impacts #insulin sensitivity. 📲 Register today: spkl.io/6019fRqBR #DiabetesResearch #Bioactivity #PharmaResearch #Elsevier


Elsevier's Insights 2024 report reveals that most researchers and clinicians view AI positively but stress the need for trust and transparency. Read more here: spkl.io/6010fRI5w #GenerativeAI #AI #LifeSciences #Research #Innovation

Tweet Image 1

🔑 Unlock the path to EU MDR approval! Gain invaluable tips on creating a successful systematic literature review process and ensuring compliance with regulatory requirements. Get the full webinar: spkl.io/6018f8zVp #EUMDR #MedicalDevices


Join us on Nov 13th and explore off-target effects, #bioactivity, and the role of #SCD1 in #diabetes treatment. Register here: spkl.io/6016fRqBE #DiabetesResearch #NationalDiabetesMonth #Elsevier


Learn how Lonza tested Reaxys Predictive Retrosynthesis in this new case study: spkl.io/6011fRBZN @LonzaGroup is a 2024 CPHI Pharma Award winner for its AI-Enabled Route Scouting Service. #Retrosynthesis #SynthesisPlanning #Research #Innovation

Tweet Image 1

Stay ahead of the curve with expert articles, in-depth analyses, and the newest trends shaping the future of life sciences at Elsevier's Life Sciences Innovation Hub. Explore now: spkl.io/6013fzIPW #Research #Elsevier


Discover a new case study that explores Lonza’s use of Reaxys Predictive Retrosynthesis: spkl.io/6011fRBkv @LonzaGroup is a 2024 CPHI Pharma Award winner for its AI-Enabled Route Scouting Service. #Retrosynthesis #SynthesisPlanning #Research #Innovation

Tweet Image 1

#Fungi, once a source of sustenance and healing, are regaining attention for their therapeutic potential. With advancements like multiplex base-editing, researchers are unlocking nature's pharmacy faster than ever. Read more: spkl.io/6013fzIYR #DrugDiscovery #Elsevier


📢 Attention medical device professionals! Discover the key criteria for a compliant systematic literature review. Find the full webinar here: spkl.io/6015f8zE5 #EUMDR #MedicalDevices


🔑 Unlock the secrets to IVDR compliance! Explore challenges in device classification, technical documentation, and more. Get a recorded webinar with notified body expert Stefan Burde, Director at TÜV SÜD: spkl.io/6012f8KQy #IVDR #RegulatoryAffairs


Did you know that the content coverage in literature databases can be country specific and some have better coverage than others in certain regions? Learn why this is important for the #EUMDR: spkl.io/6018f8Ksr #EUMDR #MedicalDevices


Dr. David Fajgenbaum, founder of @EveryCure, shares his journey from near-death to saving lives, including his', through #DrugRepurposing, with @ElsevierConnect providing the data and it's algorithms. Learn more here: spkl.io/6014f6CFM


Discover common hurdles in IVDR compliance with notified body expert Stefan Burde from TÜV SÜD. Navigate the complexities and streamline your application process. Find full webinar here: spkl.io/6018f8Kqq #IVDR #RegulatoryAffairs


Stay ahead of the curve with expert articles, in-depth analyses, and the newest trends shaping the future of life sciences at Elsevier's Life Sciences Innovation Hub. Explore now: spkl.io/6011f6C0L #Research #Elsevier


Loading...

Something went wrong.


Something went wrong.